Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.

  title={Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.},
  author={Caterina Scuderi and Daniele De Filippis and Teresa Iuvone and Angelo Blasio and Antonio Steardo and Giuseppe Esposito},
  journal={Phytotherapy research : PTR},
  volume={23 5},
Cannabidiol (CBD) is the main non-psychotropic component of the glandular hairs of Cannabis sativa. It displays a plethora of actions including anticonvulsive, sedative, hypnotic, antipsychotic, antiinflammatory and neuroprotective properties. However, it is well established that CBD produces its biological effects without exerting significant intrinsic activity upon cannabinoid receptors. For this reason, CBD lacks the unwanted psychotropic effects characteristic of marijuana derivatives, so… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 41 extracted citations


Publications referenced by this paper.
Showing 1-10 of 67 references

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.

Proceedings of the National Academy of Sciences of the United States of America • 1998
View 3 Excerpts
Highly Influenced

Controlled clinical trial of cannabidiol in Huntington's disease.

Pharmacology, biochemistry, and behavior • 1991
View 2 Excerpts
Highly Influenced

Neuroprotective effect of (-)delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite

Am J Pathol • 2008

Similar Papers

Loading similar papers…